Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes

[1]  L. Zhang.  Existence of the $(\alpha,\beta)$-Ricci-Yamabe flow on closed manifolds , 2023, 2302.03199.

[2]  Progressive Disease , 2020, Definitions.

[3]  Dan-dan Li,et al.  Improved therapeutic potential of MSCs by genetic modification , 2018, Gene Therapy.

[4]  C. Strange,et al.  Therapeutic Effects of Adipose Stem Cells from Diabetic Mice for the Treatment of Type 2 Diabetes. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Melissa M. Parker,et al.  Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes , 2018, JAMA.

[6]  Y. Mu,et al.  Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice , 2018, Cell Death & Disease.

[7]  L. Bačáková,et al.  Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. , 2018, Biotechnology advances.

[8]  C. Shao,et al.  Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases , 2018, Nature Reviews Nephrology.

[9]  F. Imbesi,et al.  Fibromyalgia Syndrome: A Case Report on Controlled Remission of Symptoms by a Dietary Strategy , 2018, Front. Med..

[10]  K. Bailey,et al.  Effects of Agricultural Organic Dusts on Human Lung-Resident Mesenchymal Stem (Stromal) Cell Function , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Yufang Shi,et al.  Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells , 2017, Cell Death & Differentiation.

[12]  D. Dean,et al.  Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies , 2017, Stem Cell Research & Therapy.

[13]  R. Bhonde,et al.  Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells Reverse Insulin Resistance in Cellular Models , 2017, Journal of cellular biochemistry.

[14]  Zhi-hao Wang,et al.  Adipose‐derived stem cells were impaired in restricting CD4+T cell proliferation and polarization in type 2 diabetic ApoE−/− mouse , 2017, Molecular immunology.

[15]  Yichong Li,et al.  Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013 , 2017, JAMA.

[16]  P. Henriet,et al.  Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation , 2017, Stem Cell Research & Therapy.

[17]  L. Pirola,et al.  Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity , 2017, World journal of biological chemistry.

[18]  P. Newsholme,et al.  The bioenergetics of inflammation: insights into obesity and type 2 diabetes , 2017, European Journal of Clinical Nutrition.

[19]  S. Mudaliar,et al.  Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. , 2017, Stem cells and development.

[20]  C. Jorgensen,et al.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis , 2017, Clinical Reviews in Allergy & Immunology.

[21]  E. Mazzon,et al.  The transplantation of mesenchymal stem cells derived from unconventional sources: an innovative approach to multiple sclerosis therapy , 2017, Archivum Immunologiae et Therapiae Experimentalis.

[22]  M. Griffin,et al.  Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy , 2017, Stem Cell Research & Therapy.

[23]  Y. Mu,et al.  Adipose-derived mesenchymal stem cells ameliorate hyperglycemia through regulating hepatic glucose metabolism in type 2 diabetic rats. , 2017, Biochemical and biophysical research communications.

[24]  K. Marycz,et al.  Basic Fibroblast Growth Factor Inhibits Apoptosis and Promotes Proliferation of Adipose-Derived Mesenchymal Stromal Cells Isolated from Patients with Type 2 Diabetes by Reducing Cellular Oxidative Stress , 2017, Oxidative medicine and cellular longevity.

[25]  S. Horman,et al.  Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Wound Healing in Type 2 Diabetes , 2016, PloS one.

[26]  J. Vendrell,et al.  Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells , 2016, Stem cells.

[27]  F. Wang,et al.  Long term effect and safety of Wharton's jelly-derived mesenchymal stem cells on type 2 diabetes. , 2016, Experimental and therapeutic medicine.

[28]  R. Mahla.  Stem Cells Applications in Regenerative Medicine and Disease Therapeutics , 2016, International journal of cell biology.

[29]  M. M. Rahman,et al.  Worldwide trends in diabetes since 1980 : pooled analysis of 751 population-based measurement studies with over 4 . 4 million participants , 2016 .

[30]  Hans Clevers,et al.  Tissue-specific designs of stem cell hierarchies , 2016, Nature Cell Biology.

[31]  T. Young,et al.  High glucose-induced reactive oxygen species generation promotes stemness in human adipose-derived stem cells. , 2016, Cytotherapy.

[32]  Y. Cheng,et al.  Human umbilical cord‐derived mesenchymal stem cells elicit macrophages into an anti‐inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats , 2016, Stem cells.

[33]  W. Cao,et al.  Mesenchymal stem cells and adaptive immune responses. , 2015, Immunology letters.

[34]  A. Salgado,et al.  Do hypoxia/normoxia culturing conditions change the neuroregulatory profile of Wharton Jelly mesenchymal stem cell secretome? , 2015, Stem Cell Research & Therapy.

[35]  Krzysztof Szade,et al.  Adult stem cells: hopes and hypes of regenerative medicine. , 2015, Acta biochimica Polonica.

[36]  S. Rutella,et al.  Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. , 2015, Gastroenterology.

[37]  H. Trivedi,et al.  Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. , 2015, Cytotherapy.

[38]  L. Dai,et al.  Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes. , 2015, Experimental and therapeutic medicine.

[39]  L. Pirola,et al.  Adipose Tissue–Derived Stem Cells From Obese Subjects Contribute to Inflammation and Reduced Insulin Response in Adipocytes Through Differential Regulation of the Th1/Th17 Balance and Monocyte Activation , 2015, Diabetes.

[40]  F. Wang,et al.  Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats. , 2015, Endocrine journal.

[41]  V. Tkachuk,et al.  Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2 , 2014, Journal of Translational Medicine.

[42]  P. Gentile,et al.  High Insulin‐Induced Down‐Regulation of Erk‐1/IGF‐1R/FGFR‐1 Signaling Is Required for Oxidative Stress‐Mediated Apoptosis of Adipose‐Derived Stem Cells , 2014, Journal of cellular physiology.

[43]  T. Berney,et al.  Has the Gap Between Pancreas and Islet Transplantation Closed? , 2014, Transplantation.

[44]  N. Khandelwal,et al.  Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study , 2014, Cell transplantation.

[45]  L. Lin,et al.  Interleukin-17 enhances immunosuppression by mesenchymal stem cells , 2014, Cell Death and Differentiation.

[46]  N. Kleinsasser,et al.  Mesenchymale Stammzellen aus Fettgewebe (ASC) – Grundlagen und Anwendung in der HNO-Heilkunde , 2014, Laryngo Rhino Otologie.

[47]  M. Fraga,et al.  Single cell‐derived clones from human adipose stem cells present different immunomodulatory properties , 2014, Clinical and experimental immunology.

[48]  Hongbing Cheng,et al.  A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus , 2014, Stem Cell Research & Therapy.

[49]  J. Rubin,et al.  Adipose stem cells: biology and clinical applications for tissue repair and regeneration. , 2014, Translational research : the journal of laboratory and clinical medicine.

[50]  H. Trivedi,et al.  In-vitro generation of human adipose tissue derived insulin secreting cells: up-regulation of Pax-6, Ipf-1 and Isl-1 , 2014, Cytotechnology.

[51]  E. Jones,et al.  Mesenchymal stem cells, autoimmunity and rheumatoid arthritis , 2014, QJM : monthly journal of the Association of Physicians.

[52]  Jian-ming Tan,et al.  Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial. , 2014, Cytotherapy.

[53]  C. Ahn,et al.  Transplantation of insulin-secreting cells differentiated from human adipose tissue-derived stem cells into type 2 diabetes mice. , 2014, Biochemical and biophysical research communications.

[54]  L. Velloso,et al.  Type 2 diabetes mellitus—an autoimmune disease? , 2013, Nature Reviews Endocrinology.

[55]  B. Gauthier,et al.  Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity , 2013, Diabetes.

[56]  M. Barba,et al.  Adipose-Derived Mesenchymal Cells for Bone Regereneration: State of the Art , 2013, BioMed research international.

[57]  R. Muralitharan,et al.  Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies , 2013, Expert opinion on biological therapy.

[58]  W. Hung,et al.  Human adipose-derived stem cells cultured in keratinocyte serum free medium: Donor’s age does not affect the proliferation and differentiation capacities , 2013, Journal of Biomedical Science.

[59]  H. Thaker,et al.  Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial , 2013, BMC Medicine.

[60]  Faizal Z. Asumda.  Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging , 2013, Stem Cell Research & Therapy.

[61]  C. Verfaillie,et al.  Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells , 2013, Immunology and cell biology.

[62]  E. Wolvetang,et al.  Differential mesengenic potential and expression of stem cell‐fate modulators in mesenchymal stromal cells from human‐term placenta and bone marrow , 2012, Journal of cellular physiology.

[63]  F. Jiao,et al.  Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages. , 2012, Cellular reprogramming.

[64]  E. Masaoud,et al.  Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. , 2012, American journal of veterinary research.

[65]  Fang Wang,et al.  Long term effects of the implantation of autologous bone marrow mononuclear cells for type 2 diabetes mellitus. , 2012, Endocrine journal.

[66]  Nicole A. Turgeon,et al.  Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010 , 2012, Diabetes Care.

[67]  E. Tobiasch,et al.  Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells , 2012, TheScientificWorldJournal.

[68]  D. Sutherland,et al.  Long-term outcome after pancreas transplantation , 2012, Current opinion in organ transplantation.

[69]  Li Wang,et al.  Autologous bone marrow stem cell transplantation for the treatment of type 2 diabetes mellitus. , 2011, Chinese medical journal.

[70]  Huey-Kang Sytwu,et al.  Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells , 2011, Journal of Biomedical Science.

[71]  Yang Xu,et al.  Immunogenicity of induced pluripotent stem cells , 2011, Nature.

[72]  Xia Li,et al.  Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study , 2011, Frontiers of medicine.

[73]  Hakan Orbay,et al.  Adipose-derived stem cells: current findings and future perspectives. , 2011, Discovery medicine.

[74]  Jian Ling,et al.  Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. , 2010, Stem cells and development.

[75]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[76]  K. Mrozik,et al.  Proteomic characterization of mesenchymal stem cell-like populations derived from ovine periodontal ligament, dental pulp, and bone marrow: analysis of differentially expressed proteins. , 2010, Stem cells and development.

[77]  N. Sachdeva,et al.  Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. , 2009, Stem cells and development.

[78]  Masayuki Orimo,et al.  A crucial role for adipose tissue p53 in the regulation of insulin resistance , 2009, Nature Medicine.

[79]  M. Gannon,et al.  Pancreas cell fate. , 2009, Birth defects research. Part C, Embryo today : reviews.

[80]  S. Phadnis,et al.  Generation of Pancreatic Hormone‐Expressing Islet‐Like Cell Aggregates from Murine Adipose Tissue‐Derived Stem Cells , 2009, Stem cells.

[81]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[82]  O. Velazquez,et al.  Combined Treatment of Intrapancreatic Autologous Bone Marrow Stem Cells and Hyperbaric Oxygen in Type 2 Diabetes Mellitus , 2008, Cell transplantation.

[83]  A. Can.  A Concise Review on the Classification and Nomenclature of Stem Cells. , 2008, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[84]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[85]  B. Morio,et al.  Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. , 2008, The Journal of clinical investigation.

[86]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[87]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[88]  J. Castell,et al.  Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. , 2006, World journal of gastroenterology.

[89]  M. Burnett,et al.  Bone Marrow–Derived Cells for Enhancing Collateral Development: Mechanisms, Animal Data, and Initial Clinical Experiences , 2004, Circulation research.

[90]  Y. Bae,et al.  Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.

[91]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion , 2003 .

[92]  S. Inzucchi.  Oral antihyperglycemic therapy for type 2 diabetes: scientific review. , 2002, JAMA.

[93]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[94]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[95]  D J Prockop,et al.  Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Levy,et al.  U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.

[97]  A. Caplan.  Mesenchymal Stem Cells , 1991, Cartilage.

[98]  Arnold I. Caplan,et al.  Mesenchymal Stem Cells , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[99]  G. I. Gallicano,et al.  Current stem cell based therapies in diabetes. , 2016, American journal of stem cells.

[100]  Z. Xi.  Efficacy and Safety of Autologous Adipose-derived Stem Cells Transplantation in Patients with Type 2 Diabetes Mellitus , 2015 .

[101]  Guihua Zhang,et al.  Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. , 2014, Clinical laboratory.

[102]  G. Vilahur,et al.  Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function , 2013, Diabetologia.

[103]  S. Cole,et al.  Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .

[104]  E. Zuckerman,et al.  2011 Update on Pancreas Transplantation: Comprehensive Trend Analysis of 25,000 Cases Followed Up Over the Course of Twenty-Four Years at the International Pancreas Transplant Registry (IPTR) , 2011 .

[105]  A. Gruessner.  2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). , 2011, The review of diabetic studies : RDS.

[106]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[107]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[108]  M. Hussain,et al.  In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. , 2003, The Journal of clinical investigation.

[109]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..